This Web Site is committed to the memory of Janis Morrow.
Latest Trials
2010
Also See : 2009
Links : Search For Clinical Trials In Your Area
Clinical Trials - General
ClinicalTrials.gov
Provides regularly updated information about federally and privately
supported clinical research in human volunteers.
Redesigned source for HCV Trials (Center Watch)
Feb 2010
Current HCV Trials
For Additional Information : VX950-TELAPREVIR
Boceprevir (SCH 503034)
| Recruiting |
Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C:
Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia
(P06086 AM1)
|
Continue Searching Boceprevir.............
Drug: PSI-7977
Click below to locate trial
| Recruiting |
Dose-Ranging Study of PSI-7977 in Combination With SOC in
Treatment Naïve GT 1 HCV Patients
|
Drug: CTS-1027, Pegylated Interferon, Ribavirin
Click below to locate trial
| Recruiting |
Study of CTS-1027 in Combination With Pegylated Interferon and
Ribavirin in Hepatitis C Virus (HCV) Null-Responders
|
Drug: SD-101; Drug: ribavirin
UPDATE 1-Dynavax hepatitis C drug shows promise in phase 1 trial
Click below to locate trial
| Recruiting |
Safety Study of SD-101 (a Novel C Type TLR9 Agonist) for the
Treatment of Chronic Hepatitis C Virus (HCV) Infection
|
TMC435
Click below to locate trial
| Condition | Intervention | Phase |
|---|---|---|
|
Hepatitis C |
Drug:
TMC435 placebo /Peg
IFNa2A/Ribavirin Drug: TMC435 /Peg IFNa2A/Ribavirin TMC435
placebo |
Phase
II |
HCV Polymerase Inhibitors
Click below to locate trial
| Recruiting |
A Study of RO5024048 in Combination With Pegasys and Copegus in
Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or
4
|
| Recruiting |
Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1
Subjects
|
| Recruiting |
A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS
And COPEGUS In Patients With Chronic Hepatitis C Genotype 1
Infection
|
| Not yet recruiting |
A Study of RO5024048 in Combination With Pegasys (Peginterferon
Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic
Hepatitis C Genotype 1 or 4
|
Schering-Plough
SCH 50304 Plus Peg-Intron, With and Without
Added Ribavirin, in Patients with Chronic Hepatitis C, Genotype 1, who
did not respond to peginterferon alfa plus ribavirin.
Click
here
for more information.
Pegylated interferon/Ribavirin
Click below to locate trial
| Recruiting |
Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended
Treatment in HCV-Genotype 2/3 Patients
|
Hepatitis C in a Cohort of Patients With Maintenance Therapy
for Opiate Dependence - Prevalence, Severity and Outcome of
Antiviral Therapy
|
Continue Searching.............
RSS Feeds for
studies found by your search that were:
Feb 2010
Jan
Below are a few examples of currently recruiting trials for HCV
| Recruiting |
Boceprevir/Peginterferon/Ribavirin for Chronic
Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction
for Anemia (P06086 AM1)
|
| Recruiting |
A Phase 2b, Safety and Efficacy Study of
Boceprevir in Patients Coinfected With HIV and Hepatitis C
(P05411 AM3)
|
| Recruiting |
Peginterferon Alfa-2a Plus
Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and
Chronic Hepatitis C
|
| Recruiting |
Interest of Ribavirin in the
Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated
Interferon alpha2b in Patients With Chronic Hepatitis C Non
Responders to Previous Antiviral Therapy.
|
| Recruiting |
Pegylated Interferon Plus
Ribavirin in Treating Older Patients With Chronic Hepatitis C
|
To Continue Searching Click Here
Helpful Information
From HCV Advocate
Hepatitis C Treatments in Current Clinical Development
Quality of Life: Effects of Hepatitis C and Its Treatment
AASLD 2009: Part 1 AASLD 2010: Part 2
Page Updated Feb 1 2010